{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T17:08:48Z","timestamp":1765732128268,"version":"3.48.0"},"reference-count":82,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,2,23]]},"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>This protocol presents the rationale and design for a trial evaluating the efficacy of intranasal oxytocin in improving pain and function among women with chronic pelvic musculoskeletal pain. Oxytocin is a neuropeptide traditionally recognised for involvement in labour, delivery and lactation. Novel evidence suggests that oxytocin decreases pain sensitivity in humans. While oxytocin administration has been reported to lower pain sensitivity among patients experiencing chronic back pain, headache, constipation and colon pain, no research has evaluated the association between intranasal oxytocin and chronic pelvic musculoskeletal pain. The association between oxytocin and pain may differ in women with chronic pelvic musculoskeletal pain relative to other chronic pain conditions because of the abundance of oxytocin receptors in the uterus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a prospective, randomised, placebo-controlled, double-blind, within-participants crossover trial. 50 women with chronic pelvic musculoskeletal pain will be recruited through a local chronic pain centre and gynaecology clinics. Women will complete baseline measures and be randomised to an experimental or control condition that involve 2\u2005weeks of self-administering twice-daily doses of 24\u2005IU intranasal oxytocin or placebo, respectively. Women will then undergo a 2-week washout period before crossing over to receive the condition that they had not yet received. The primary outcome will be pain and function measured using the Brief Pain Inventory-Short Form. Secondary outcomes include emotional function, sleep disturbance and global impression of change. This trial will provide data on the 14-day safety and side-effect profile of intranasal oxytocin self-administered as an adjuvant treatment for chronic pelvic musculoskeletal pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>\n                      This trial was granted approval from Health Canada and the University of Calgary Conjoint Health Research Ethics Board, and is registered online at ClinicalTrials.gov (#\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT02888574\">NCT02888574<\/jats:ext-link>\n                      ). Results will be disseminated to healthcare professionals through peer-reviewed publications and to the general public through press releases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02888574\" ext-link-type=\"uri\">NCT02888574<\/jats:ext-link>\n                      ; Pre-results.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2016-014909","type":"journal-article","created":{"date-parts":[[2017,4,17]],"date-time":"2017-04-17T20:10:17Z","timestamp":1492459817000},"page":"e014909","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Protocol for a placebo-controlled, within-participants crossover trial evaluating the efficacy of intranasal oxytocin to improve pain and function among women with chronic pelvic musculoskeletal pain"],"prefix":"10.1136","volume":"7","clinical-trial-number":[{"clinical-trial-number":"nct02888574","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02888574","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Joshua A","family":"Rash","sequence":"first","affiliation":[{"name":"Department of Psychology, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Psychology, Memorial University of Newfoundland, St. John's, Newfoundland, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsti","family":"Toivonen","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magali","family":"Robert","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Nasr-Esfahani","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F","family":"Jarrell","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tavis S","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,4,16]]},"reference":[{"key":"2025121409065680000_7.4.e014909.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2010.00185.x"},{"key":"2025121409065680000_7.4.e014909.2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1152\/physrev.2001.81.2.629","article-title":"The oxytocin receptor system: structure, function, and regulation","volume":"81","author":"Gimpl","year":"2001","journal-title":"Physiol Rev"},{"key":"2025121409065680000_7.4.e014909.3","doi-asserted-by":"publisher","DOI":"10.1126\/science.6278592"},{"key":"2025121409065680000_7.4.e014909.4","first-page":"713","article-title":"The effect of intranasal oxytocin on lactation","volume":"21","author":"Luhman","year":"1963","journal-title":"Obstet Gynecol"},{"key":"2025121409065680000_7.4.e014909.5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/AJP.0b013e31829f57df","article-title":"Oxytocin and pain: a systematic review and synthesis of findings","volume":"30","author":"Rash","year":"2014","journal-title":"Clin J Pain"},{"key":"2025121409065680000_7.4.e014909.6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neubiorev.2015.04.013","article-title":"Oxytocin and the modulation of pain experience: implications for chronic pain management","volume":"55","author":"Tracy","year":"2015","journal-title":"Neurosci Biobehav Rev"},{"key":"2025121409065680000_7.4.e014909.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2011.02.015"},{"key":"2025121409065680000_7.4.e014909.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2008.10.030"},{"key":"2025121409065680000_7.4.e014909.9","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1523\/JNEUROSCI.18-07-02377.1998","article-title":"Oxytocin modulates glutamatergic synaptic transmission between cultured neonatal spinal cord dorsal horn neurons","volume":"18","author":"Jo","year":"1998","journal-title":"J Neurosci"},{"key":"2025121409065680000_7.4.e014909.10","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-4-19"},{"key":"2025121409065680000_7.4.e014909.11","unstructured":"Melzack R , Wall PD . The challenge of pain. 2nd edn. New York, NY: Penguin Books, 1988."},{"key":"2025121409065680000_7.4.e014909.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(01)03346-7"},{"key":"2025121409065680000_7.4.e014909.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2011.03.007"},{"key":"2025121409065680000_7.4.e014909.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2006.01.029"},{"key":"2025121409065680000_7.4.e014909.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(03)00465-7"},{"key":"2025121409065680000_7.4.e014909.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.01.014"},{"key":"2025121409065680000_7.4.e014909.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.08.022"},{"key":"2025121409065680000_7.4.e014909.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(99)00183-9"},{"key":"2025121409065680000_7.4.e014909.19","doi-asserted-by":"publisher","DOI":"10.1097\/00007632-199404150-00001"},{"key":"2025121409065680000_7.4.e014909.20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.npep.2012.12.003","article-title":"The interaction between the oxytocin and pain modulation in headache patients","volume":"47","author":"Wang","year":"2013","journal-title":"Neuropeptides"},{"key":"2025121409065680000_7.4.e014909.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2005.00679.x"},{"key":"2025121409065680000_7.4.e014909.22","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.5.741"},{"key":"2025121409065680000_7.4.e014909.23","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00296-014-2953-y","article-title":"Oxytocin nasal spray in fibromyalgic patients","volume":"34","author":"Mameli","year":"2014","journal-title":"Rheumatol Int"},{"key":"2025121409065680000_7.4.e014909.24","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(95)00214-6"},{"key":"2025121409065680000_7.4.e014909.25","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(95)00458-0"},{"key":"2025121409065680000_7.4.e014909.26","doi-asserted-by":"publisher","DOI":"10.1053\/beog.1999.0083"},{"key":"2025121409065680000_7.4.e014909.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2012.07.001"},{"key":"2025121409065680000_7.4.e014909.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2011.10.001"},{"key":"2025121409065680000_7.4.e014909.29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000251"},{"key":"2025121409065680000_7.4.e014909.30","doi-asserted-by":"crossref","unstructured":"Senn S . Cross-over trials in clinical research. 2nd edn. San Francisco, CA: John Wiley & Sons, 2002.","DOI":"10.1002\/0470854596"},{"key":"2025121409065680000_7.4.e014909.31","doi-asserted-by":"crossref","unstructured":"Pfleeger M , Straneva PA , Fillingim RB , et al . Menstrual cycle, blood pressure and ischemic pain sensitivity in women: a preliminary investigation. Int J Psychophysiol 1997;27:161\u20136.","DOI":"10.1016\/S0167-8760(97)00058-5"},{"key":"2025121409065680000_7.4.e014909.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(98)00258-9"},{"key":"2025121409065680000_7.4.e014909.33","doi-asserted-by":"crossref","unstructured":"Vleeming A , Albert HB , Ostgaard HC , et al . European guidelines for the diagnosis and treatment of pelvic girdle pain. Eur Spine J 2008;17:794\u2013819. doi:10.1007\/s00586-008-0602-4","DOI":"10.1007\/s00586-008-0602-4"},{"key":"2025121409065680000_7.4.e014909.34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.24.14558"},{"key":"2025121409065680000_7.4.e014909.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6123(02)39024-1"},{"key":"2025121409065680000_7.4.e014909.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2012.11.019"},{"key":"2025121409065680000_7.4.e014909.37","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fnins.2012.00174","article-title":"Elevated salivary levels of oxytocin persist more than 7\u2005h after intranasal administration","volume":"6","author":"Van IJzendoorn","year":"2012","journal-title":"Front Neurosci"},{"key":"2025121409065680000_7.4.e014909.38","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00296-014-3070-7","article-title":"Future directions for the investigation of intranasal oxytocin and pain: Comment on: Oxytocin nasal spray in fibromyalgic patients (Rheumatol Int. E-pub ahead of print. doi: 10.1007\/s00296-014-2953-y)","volume":"34","author":"Rash","year":"2014","journal-title":"Rheumatol Int"},{"key":"2025121409065680000_7.4.e014909.39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-002360"},{"key":"2025121409065680000_7.4.e014909.40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000368"},{"key":"2025121409065680000_7.4.e014909.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.09.012"},{"key":"2025121409065680000_7.4.e014909.42","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singap"},{"key":"2025121409065680000_7.4.e014909.43","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-200409000-00005"},{"key":"2025121409065680000_7.4.e014909.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2005.06.002"},{"key":"2025121409065680000_7.4.e014909.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2003.12.005"},{"key":"2025121409065680000_7.4.e014909.46","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1477-7525-8-148","article-title":"Psychometric properties of the Brief Pain Inventory among patients with osteoarthritis undergoing total hip replacement surgery","volume":"8","author":"Kapstad","year":"2010","journal-title":"Health Qual Life Outcomes"},{"key":"2025121409065680000_7.4.e014909.47","unstructured":"Cleeland C . The brief pain inventory: user guide. TX: M.D. Anderson Cancer Center, University of Texas, 2009."},{"key":"2025121409065680000_7.4.e014909.48","doi-asserted-by":"publisher","DOI":"10.1037\/0022-3514.54.6.1063"},{"key":"2025121409065680000_7.4.e014909.49","doi-asserted-by":"crossref","unstructured":"Lovibond P . Manual for the depression anxiety stress scales. Sydney: Sydney Psychology, 1995.","DOI":"10.1037\/t01004-000"},{"key":"2025121409065680000_7.4.e014909.50","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-7967(96)00068-X"},{"key":"2025121409065680000_7.4.e014909.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.01.023"},{"key":"2025121409065680000_7.4.e014909.52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2010.01005.x"},{"key":"2025121409065680000_7.4.e014909.53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jpsychores.2007.05.015","article-title":"Psychometric properties of the DASS-Depression scale among a Brazilian population with chronic pain","volume":"64","author":"Sarda","year":"2008","journal-title":"J Psychosom Res"},{"key":"2025121409065680000_7.4.e014909.54","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10862-013-9391-0","article-title":"Depression Anxiety Stress Scales-21: factor structure and test-retest invariance, and temporal stability and uniqueness of latent factors in older adults","volume":"36","author":"Gomez","year":"2014","journal-title":"J Psychopathol Behav Assess"},{"key":"2025121409065680000_7.4.e014909.55","doi-asserted-by":"crossref","unstructured":"Hays RD , Stewart A . Ch14: Sleep measures. In: AL Stewart, JE Ware eds. Measuring Functioning and Well Being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press. 1992;235\u2013259.","DOI":"10.7249\/CB361"},{"key":"2025121409065680000_7.4.e014909.56","first-page":"229","article-title":"The relationship between insomnia and health-related quality of life in patients with chronic illness","volume":"51","author":"Katz","year":"2002","journal-title":"J Fam Pract"},{"key":"2025121409065680000_7.4.e014909.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2004.07.006"},{"key":"2025121409065680000_7.4.e014909.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2006.05.002"},{"key":"2025121409065680000_7.4.e014909.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmpt.2003.11.003"},{"key":"2025121409065680000_7.4.e014909.60","first-page":"2683","article-title":"Responsiveness of fibromyalgia clinical trial outcome measures","volume":"27","author":"Dunkl","year":"2000","journal-title":"J Rheumatol"},{"key":"2025121409065680000_7.4.e014909.61","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(01)00349-9"},{"key":"2025121409065680000_7.4.e014909.62","doi-asserted-by":"publisher","DOI":"10.1037\/0278-6133.19.6.586"},{"key":"2025121409065680000_7.4.e014909.63","doi-asserted-by":"publisher","DOI":"10.1037\/1040-3590.7.4.524"},{"key":"2025121409065680000_7.4.e014909.64","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025570508954"},{"key":"2025121409065680000_7.4.e014909.65","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005548801037"},{"key":"2025121409065680000_7.4.e014909.66","doi-asserted-by":"publisher","DOI":"10.1177\/1359105308093866"},{"key":"2025121409065680000_7.4.e014909.67","doi-asserted-by":"publisher","DOI":"10.1207\/s15327752jpa5201_2"},{"key":"2025121409065680000_7.4.e014909.68","doi-asserted-by":"publisher","DOI":"10.1080\/13607869856669"},{"key":"2025121409065680000_7.4.e014909.69","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-7916(00)00012-4"},{"key":"2025121409065680000_7.4.e014909.70","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.cct.2012.04.008","article-title":"The measurement of symptoms and side effects in clinical trials of chronic pain","volume":"33","author":"Katz","year":"2012","journal-title":"Contemp Clin Trials"},{"key":"2025121409065680000_7.4.e014909.71","doi-asserted-by":"crossref","unstructured":"Kristjanson L , Pickstock S , Yuen K , et al . Development and testing of the revised Symptom Assessment Scale (SAS): final report. Perth, WA: Edith Cowan University, 1999.","DOI":"10.1037\/t36926-000"},{"key":"2025121409065680000_7.4.e014909.72","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/PSY.0000000000000068","article-title":"The effect of intranasal oxytocin administration on acute cold pressor pain: a placebo-controlled, double-blind, within-participants crossover investigation","volume":"76","author":"Rash","year":"2014","journal-title":"Psychosom Med"},{"key":"2025121409065680000_7.4.e014909.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2007.09.005"},{"key":"2025121409065680000_7.4.e014909.74","doi-asserted-by":"publisher","DOI":"10.3758\/BRM.41.4.1149"},{"key":"2025121409065680000_7.4.e014909.75","first-page":"1339","article-title":"Intention-to-treat principle","volume":"165","author":"Montori","year":"2001","journal-title":"CMAJ"},{"key":"2025121409065680000_7.4.e014909.76","doi-asserted-by":"crossref","unstructured":"Harrell F . Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis. New York, NY: Springer, 2001.","DOI":"10.1007\/978-1-4757-3462-1"},{"key":"2025121409065680000_7.4.e014909.77","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.tips.2014.09.004","article-title":"Oxytocin and analgesia: future trends","volume":"35","author":"Gonz\u00e1lez-Hern\u00e1ndez","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"2025121409065680000_7.4.e014909.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2004.12.010"},{"key":"2025121409065680000_7.4.e014909.79","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.06.028"},{"key":"2025121409065680000_7.4.e014909.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2006.12.005"},{"key":"2025121409065680000_7.4.e014909.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2010.07.006"},{"key":"2025121409065680000_7.4.e014909.82","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2013.13"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2016-014909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T17:07:05Z","timestamp":1765732025000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2016-014909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":82,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4,16]]},"published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1136\/bmjopen-2016-014909"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2016-014909","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}